Order Article Reprints

Chang B-S, Peng T-C, Wu Y-F, Hsieh T-C, Huang C-H. Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. Journal of Personalized Medicine. 2022; 12(3):404. https://doi.org/10.3390/jpm12030404

Chang, Bee-Song, Tai-Chu Peng, Yi-Feng Wu, Tsung-Cheng Hsieh, and Chun-Hou Huang. 2022. "Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors" Journal of Personalized Medicine 12, no. 3: 404. https://doi.org/10.3390/jpm12030404

Chang, B.-S., Peng, T.-C., Wu, Y.-F., Hsieh, T.-C., & Huang, C.-H. (2022). Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. Journal of Personalized Medicine, 12(3), 404. https://doi.org/10.3390/jpm12030404